LDIC Inc. ("LDIC" or the "Manager") announces that it has extended the deadline for the deposit of exchange eligible securities with respect to the initial public offering (the "Offering") of Class A Units and Class U Units of Healthcare Special Opportunities Fund (the "Fund").

Prospective purchasers investing in the Fund under the exchange option are now permitted to deposit their exchange eligible securities prior to 5:00 p.m. (Toronto time) on July 10, 2015 in the manner described in the preliminary prospectus of the Fund dated May 29, 2015 (the "Preliminary Prospectus"). Such deposits must be made in the form of a book-entry deposit with Equity Financial Trust Company, the Fund's agent for the Exchange Option, through CDS Clearing and Depository Services Inc. ("CDS"). Investment dealers, who will make these deposits through CDS, may have an earlier deadline for receiving instructions from investment advisors to deposit securities under the Exchange Option. The Pricing Period for the Exchange Option has also been extended and will be five consecutive trading days ending on July 10, 2015. The Fund will issue a press release as soon as practicable after the end of the Pricing Period announcing for each of the exchange eligible securities, among other things, the Exchange Ratio.

The Fund has filed and obtained a receipt from the securities regulatory authorities in each of the provinces of Canada for the Preliminary Prospectus. The Fund proposes to issue Class A Units and Class U Units at a price of $10.00 per Class A Unit and U.S.$10.00 per Class U Unit. The Class U Units will not be listed on a stock exchange, but are convertible into Class A Units on a weekly basis. The Class U Units are designed for investors wishing to make their investments in U.S. dollars.

The Fund's investment objective is to provide Unitholders with long-term total return through distributions and capital appreciation of the Fund's investment portfolio. The Fund has been created to invest in an actively managed portfolio comprised primarily of publicly traded issuers and private issuers that derive a significant portion of their revenue or earnings from medical and healthcare products and/or services. The Fund may invest up to 20% of the Fund's total assets in private equity investments to provide investors with exposure to a limited number of investments that the Manager believes have potential for significant upside.

LDIC will be responsible for the execution of the Fund's overall investment strategy, including managing the composition of the Portfolio. Canons Park Advisors, Inc., carrying on business as Dalsin Greene Advisors, will provide LDIC with ongoing analysis regarding the global healthcare sector, including private equity investments.

The syndicate of agents for the Offering is being co-led by BMO Capital Markets and Scotiabank, and includes Canaccord Genuity Corp., GMP Securities L.P., Mackie Research Capital Corporation, Salman Partners Inc., Desjardins Securities Inc., Dundee Securities Ltd., Global Securities Corporation, Industrial Alliance Securities Inc., Laurentian Bank Securities Inc., and PI Financial Corp. (collectively, the "Agents").

Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions "expect", "intend", "will", and similar expressions to the extent they relate to the Fund and/or the Manager. The forward-looking statements are not historical facts but reflect the Fund's and/or the Manager's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although the Fund and/or the Manager believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. The Fund and/or the Manager undertake no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other such factors which affect this information, except as required by law.

A preliminary prospectus dated May 29, 2015 (the "Preliminary Prospectus") containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces of Canada. The Preliminary Prospectus is still subject to completion or amendment. Copies of the Preliminary Prospectus may be obtained from any of the Agents. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued.

All capitalized terms noted herein but not defined are as defined in the Prospectus.

For additional information or a copy of the Prospectus, please contact your registered financial advisor.

Contact Information:

Genevieve Roch-Decter